- Home
- About Us
- Our Products
- Investors
- News
- New Product Pipeline
- Contact Us
Pharmaxis is a specialist pharmaceutical company that researches, develops and commercialises new therapies for undertreated respiratory diseases.
Founded on an Australian discovery, Pharmaxis' products are now available worldwide. 

Pharmaxis is pleased to announce it has received Marketing Authorisation for Bronchitol from the European Commission.

Bronchitol has been recommended for listing on the Pharmaceutical Benefits Scheme for the treatment of cystic fibrosis.![]()